Centre for Research in Intensive Care (CRIC)
5
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
100%
5 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial
Role: collaborator
Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.
Role: collaborator
Agents Intervening Against Delirium in Intensive Care Unit
Role: collaborator
The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19
Role: collaborator
Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia
Role: collaborator
All 5 trials loaded